MedTrace Logo

Serum Cholesterol and Gastric Neoplasm

NCT02041312 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1178

Last updated 2016-12-06

No results posted yet for this study

Summary

Investigators have a plan to conduct nested case-control study to investigate the association between serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins and gastric neoplasm. In addition, further analyses were performed to evaluate the possible role of the serum cholesterol as a predictor for the differentiation and prognosis of gastric neoplasm.

Conditions

Interventions

OTHER

No intervention

No intervention will be needed.

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Hwoon-Yong Jung, M.D., PhD. · Asan Medical Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2018-12-31
Completion
2019-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02041312 on ClinicalTrials.gov